Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis

May 22, 2011 in Medical research

A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor (TNF), can also suppress aspects of inflammation. The researchers say the identification of the mechanism of how this occurs could potentially lead to new treatments for diseases such as rheumatoid arthritis. The study was published May 22 online in advance of publication in the journal Nature Immunology.

"Prior to this study, TNF has long been known as a potent pro-inflammatory cytokine, but if you look carefully through the literature, there are hints that it also has some suppressive functions, but nothing was known about the mechanisms," said Lionel Ivashkiv, M.D., associate chief scientific officer and physician in the Arthritis and Tissue Degeneration Program at Hospital for Special Surgery who led the study. "This is really the first mechanism showing how TNF can turn down."

Because many proteins have homeostatic functions, both driving and suppressing certain actions so a cell can maintain internal equilibrium, researchers thought TNF might not be an exception. "Most strong activators in the immune system trigger a feedback response to restrain the amount of inflammation," Dr. Ivashkiv said.

To find out, researchers designed experiments stimulating macrophages with (LPS), a prototypical inflammatory factor that stimulates important in inflammation. In studies, the researchers treated human monocytes and macrophages, cells that have a key role in , with TNF and then challenged these cells with LPS. They found that the TNF suppressed the of the macrophages and monocytes. They then gave mice low doses of TNF followed by high doses of LPS and found that the mice were protected from the effects of high dose LPS, which is usually lethal. They discovered that the mechanism by which TNF suppressed the inflammatory response involved a protein known as GSK3 (glycogen synthase kinase 3-alpha) and a gene known as TNFAIP3 that encodes the A20 protein. Experiments with a drug that can inhibit GSK3 as well as experiments with RNA interference of A20, which can block A20 gene function, helped identify the roles of this protein and gene.

The researchers say the findings could be used to develop potential therapies for diseases, such as rheumatoid arthritis. "We think it is relevant to rheumatoid arthritis, not only because the cells we are studying (the macrophages) are exactly the same cells that migrate into joints and make the inflammatory cytokines involved in rheumatoid arthritis, but because A20 is involved. TNFAIP3 is one of the best linked genes to rheumatoid arthritis," Dr. Ivashkiv said. "There are polymorphisms in the A20 gene that have been linked to RA pathogenesis."

The researchers hypothesize that patients who make less A20 are more susceptible to inflammation and thus rheumatoid arthritis. One approach to treating RA could be to increase A20 levels in patients who naturally make less A20 by manipulating GSK-3, since this study showed that GSK-3 influences A20. "The study sort of opens a line of investigation to understanding how A20 levels can be manipulated in patients with various diseases," Dr. Ivashkiv said.

The findings could be applied to other diseases besides arthritis. In conditions such as , you may want to boost A20, but in other settings such as cancer, where the macrophages are suppressed, you may want to inhibit A20 expression.

"What the study shows that is new is that TNF has suppressive functions in addition to its well-known activating functions," Dr. Ivashkiv said. "Before this study, people thought it might suppress adaptive immunity, but surprisingly we found that it actually suppresses a cell of the innate immune system, the macrophage, which is the same cell that makes it and, by doing that, it regulates its own production."

Provided by Hospital for Special Surgery

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    created12 hours ago
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

A revealing hand

What did you have for lunch yesterday? How many times a month do you eat nuts? How about your kids -- how many servings of vegetables did they consume today?

Medical research created 55 minutes ago | popularity 5 / 5 (1) | comments 0

Stem-cell-growing surface enables bone repair

(Medical Xpress) -- University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. ...

Medical research created 16 hours ago | popularity 5 / 5 (7) | comments 1 | with audio podcast

Hormone plays surprise role in fighting skin infections

Antimicrobial peptides (AMPs) are molecules produced in the skin to fend off infection-causing microbes. Vitamin D has been credited with a role in their production and in the body's overall immune response, ...

Medical research created 17 hours ago | popularity not rated yet | comments 0 | with audio podcast

Aggregating instead of stabilizing: New insights into the mechanisms of heart disease

Malformed desmin proteins aggregate with intact proteins of the same kind, thereby triggering skeletal and cardiac muscle diseases, the desminopathies. This was discovered by researchers from the RUB Heart and Diabetes Center ...

Medical research created 21 hours ago | popularity not rated yet | comments 0

Array of light for early disease detection?

A special feature in this week's issue of the journal Science highlights protein array technology, touching on research conducted by Joshua LaBaer, director of the Biodesign Institute's Virginia G. Piper ...

Medical research created May 22, 2012 | popularity not rated yet | comments 0 | with audio podcast


Spatial configuration can spark deja vu, psychology study reveals

(Medical Xpress) -- Déjà vu - that strange feeling of having experienced something before - is more likely to occur when a scene's spatial layout resembles one in memory, according to groundbreaking new research ...

New genetic method pinpoints geographic origin

(Medical Xpress) -- Understanding the genetic diversity within and between populations has important implications for studies of human disease and evolution. This includes identifying associations between genetic variants ...

World's biggest stroke clot-buster trial reveals patient benefits

(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.

Expert: Medicaid cuts will hurt low-, middle-income Illinois seniors

(Medical Xpress) -- Springfield’s plan to slash nearly $1.4 billion from the state’s Medicaid program will ultimately result in bigger medical (and financial) problems for low- and middle-income ...

Professor conducting study to determine whether supplements help muscles grow

Nutritional supplements are often associated with athletes and body builders, but a University of Kansas professor is conducting a research project to determine whether they are in fact, effective and if they might be able ...

No new neurons in the human olfactory bulb

(Medical Xpress) -- Research from Karolinska Institutet shows that the human olfactory bulb - a structure in the brain that processes sensory input from the nose - differs from that of other mammals in that no new neurons ...